Exploring the distinctive biological characteristics of pilocytic and low-grade diffuse astrocytomas using microarray gene expression profiles

Journal of Neuropathology and Experimental Neurology

Volumn 65, Issue 8, 2006, Pages 794-807

  Rorive, Sandrine ^a   Maris, Calliope ^a   Debeir, Olivier ^b   Sandras, Flavienne ^a   Vidaud, Michel ^c   Bièche, Ivan ^c   Salmon, Isabelle ^a,d   Decaestecker, Christine ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c INSERM   (France)

^d ERASME HOSPITAL   (Belgium)

Author keywords

Cell migration; Diffuse astrocytoma; Gene microarray; Molecular marker; Pilocytic astrocytoma

Indexed keywords

AGGRECAN; APOLIPOPROTEIN D; CHONDROADHERIN; COLLAGEN TYPE 9; COMPLEMENT INHIBITOR; COMPLEMENTARY DNA; DRUG; EPIDERMAL GROWTH FACTOR RECEPTOR; LIPOPROTEIN LIPASE; MOLECULAR MARKER; OSTEONECTIN; PROTEOCHONDROITIN SULFATE; SEMAPHORIN 5A; SOMATOMEDIN BINDING PROTEIN 2; THROMBOSPONDIN 4; TISSUE INHIBITOR OF METALLOPROTEINASE 4; TRANSDUCIN; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTOMA; BRAIN TISSUE; CANCER CLASSIFICATION; CANCER GRADING; CELL INVASION; CHAD GENE; CINH GENE; DIFFUSE ASTROCYTOMA; DNA MICROARRAY; EXTRACELLULAR MATRIX; GENE; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; HUMAN; IGFBP2 GENE; MOLECULAR MODEL; PILOCYTIC ASTROCYTOMA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THBS4 GENE; TIMP4 GENE; TLE2 GENE; VALIDATION PROCESS;

ADULT; ASTROCYTOMA; BRAIN NEOPLASMS; CELL ADHESION; CELL MOVEMENT; CHILD; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MODELS, NEUROLOGICAL; NEOPLASM INVASIVENESS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 33746881103     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jnen.0000228203.12292.a1     Document Type: Article

References (69)

1. Perry A. Pathology of low-grade gliomas: An update of emerging concepts. Neurooncology 2003;5:168-78
2. Giannini C, Scheithauer BW. Classification and grading of low-grade astroc-tic tumors in children. Brain Pathol 1997;7:785-98
3. Kleihues P, Cavenee WK. Pathology and Genetics of Tumours of the Nervous System. World Health Organization Classification of Tumours. Lyon: IARC Press, 2000
4. Kleihues P, Louis DN, Scheithauer BW, et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 2002;61:215-25
5. Tihan T, Fisher PG, Kepner J, et al. Pediatric astrocytomas with monomorphous pilomyxoid features and a less favorable outcome. J Neuropathol Exp Neurol 1999;58:1061-68
6. Sallinen SL, Sallinen P, Haapasalo H, et al. Accumulation of genetic changes is associated with poor prognosis in grade II astrocytomas. Am J Pathol 1997;151:1799-807
7. Wessels PH, Twijnstra A, Kessels AG, et al. Gain of chromosome 7, as detected by in situ hybridization, strongly correlates with shorter survival in astrocytoma grade 2. Genes Chromosomes Cancer 2002;33:279-84
8. Nutt CL, Mani DR, Betensky RA, et al. Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Res 2003;63:1602-7
9. Huang H, Colella S, Kurrer M, et al. Gene expression profiling of low-grade diffuse astrocytomas by cDNA arrays. Cancer Res 2000;60:6868-74
10. Sallinen SL, Sallinen PK, Haapasalo HK, et al. Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques. Cancer Res 2000;60:6617-22
11. Godard S, Getz G, Delorenzi M, et al. Classification of human astrocytic gliomas on the basis of gene expression: A correlated group of genes with angiogenic activity emerges as a strong predictor of subtypes. Cancer Res 2003;63:6613-25
12. Hunter S, Young A, Olson J, et al. Differential expression between pilocytic and anaplastic astrocytomas: Identification of apolipoprotein D as a marker for low-grade, non-infiltrating primary CNS neoplasms. J Neuropathol Exp Neurol 2002;61:275-81
13. Rickman DS, Bobek MP, Misek DE, et al. Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis. Cancer Res 2001;61:6885-91
14. Gutmann DH, Hedrick NM, Li J, et al. Comparative gene expression profile analysis of neurofibromatosis 1-associated and sporadic pilocytic astrocytomas. Cancer Res 2002;62:2085-91
15. Khatua S, Peterson KM, Brown KM, et al. Overexpression of the EGFR/FKBP12/HIF-2alpha pathway identified in childhood astrocytomas by angiogenesis gene profiling. Cancer Res 2003;63:1865-70
16. Ljubimova JY, Lakhter AJ, Loksh A, et al. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis. Cancer Res 2001;61:5601-10
17. van den Boom J, Wolter M, Kuick R, et al. Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction. Am J Pathol 2003;163:1033-43
18. Wong KK, Chang YM, Tsang YT, et al. Expression analysis of juvenile pilocytic astrocytomas by oligonucleotide microarray reveals two potential subgroups. Cancer Res 2005;65:76-84
19. Huang H, Hara A, Homma T, et al. Altered expression of immune defense genes in pilocytic astrocytomas. J Neuropathol Exp Neurol 2005;64:891-901
20. Rhodes DR, Yu J, Shanker K. Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc Natl Acad Sci U S A 2004;101:9309-14
21. Moreau Y, Aerts S, De Moor B, et al. Comparison and meta-analysis of microarray data: From the bench to the computer desk. Trends Genet 2003;19:570-77
22. Bieche I, Parfait B, Le Doussal V, et al. Identification of CGA as a novel estrogen receptor-responsive gene in breast cancer: An outstanding candidate marker to predict the response to endocrine therapy. Cancer Res 2001;61:1652-58
23. Zar JH. Biostatistical Analysis, 4th ed. Upper Saddle River, NJ: Prentice Hall International, 2003
24. Sigel S, Catellan NJ Jr. Nonparametric Statistics for the Behavioral Sciences, 2nd ed. Singapore: McGraw-Hill International Editions, 1988
25. Buesa C, Maes T, Subirada F. DNA chip technology in brain banks: Confronting a degrading world. J Neuropathol Exp Neurol 2004;63:1003-14
26. Giese A, Bjerkvig R, Berens ME, et al. Cost of migration: Invasion of malignant gliomas and implications for treatment. J Clin Oncol 2003;21:1624-36
27. Lampert K, Machein U, Machein MR, et al. Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors. Am J Pathol 1998;153:429-37
28. Bellail AC, Hunter SB, Brat DJ, et al. Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion. Int J Biochem Cell Biol 2004;36:46-69
29. Bigg HF, Morrison CJ, Butler GS, et al. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase. Cancer Res 2001;61:3610-18
30. Dzwonek J, Rylski M, Kaczmarek L. Matrix metalloproteinases and their endogenous inhibitors in neuronal physiology of the adult brain. FEBS Lett 2004;567:129-35
31. Liu YE, Wang M, Greene J. Preparation and characterization of recombinant tissue inhibitor of metalloproteinase 4 (TIMP-4). J Biol Chem 1997;272:20479-83
32. Ratnoff OD, Pensky J, Ogston D, et al. The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C′1r subcomponent of the first component of complement by serum C′1 esterase inhibitor. J Exp Med 1969;129:315-31
33. Belien AT, Paganetti PA, Schwab ME. Membrane-type 1 matrix metalloprotease (MT1-MMP) enables invasive migration of glioma cells in central nervous system white matter. J Cell Biol 1999;144:373-84
34. Sethi CS, Bailey TA, Luthert PJ, et al. Matrix metalloproteinase biology applied to vitreoretinal disorders. Br J Ophthalmol 2000;84:654-66
35. Faisal Khan KM, Laurie GW, McCaffrey TA, et al. Exposure of cryptic domains in the alpha1-chain of laminin-1 by elastase stimulates macrophages urokinase and matrix metalloproteinase-9 expression. J Biol Chem 2002;277:13778-86
36. Asahi M, Wang X, Mori T, et al. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J Neurosci 2001;21:7724-32
37. Mizuno M, Fujisawa R, Kuboki Y. Bone chondroadherin promotes attachment of osteoblastic cells to solid-state substrates and shows affinity to collagen. Calcif Tissue Int 1996;59:163-67
38. Mansson B, Wenglen C, Morgelin M, et al. Association of chondroadherin with collagen type II. J Biol Chem 2001;276:32883-88
39. Wiberg C, Klatt AR, Wagener R, et al. Complexes of matrilin-1 and biglycan or decorin connect collagen VI microfibrils to both collagen II and aggrecan. J Biol Chem 2003;278:37698-704
40. Arber S, Caroni P. Thrombospondin-4, an extracellular matrix protein expressed in the developing and adult nervous system promotes neurite outgrowth. J Cell Biol 1995;131:1083-94
41. Narouz-Ott L, Maurer P, Nitsche DP, et al. Thrombospondin-4 binds specifically to both collagenous and non-collagenous extracellular matrix proteins via its C-terminal domains. J Biol Chem 2000;275:37110-17
42. Firth SM, Baxter RC. Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 2002;23:824-54
43. Kelley KM, Oh Y, Gargosky SE, et al. Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics. Int J Biochem Cell Biol 1996;28:619-37
44. Menouny M, Binoux M, Babajko S. Role of insulin-like growth factor binding protein-2 and its limited proteolysis in neuroblastoma cell proliferation: Modulation by transforming growth factor-beta and retinoic acid. Endocrinology 1997;138:683-90
45. Wang H, Wang H, Shen W, et al. Insulin-like growth factor binding protein 2 enhances glioblastoma invasion by activating invasion-enhancing genes. Cancer Res 2003;63:4315-21
46. Elmlinger MW, Deininger MH, Schuett BS, et al. In vivo expression of insulin-like growth factor-binding protein-2 in human gliomas increases with the tumor grade. Endocrinology 2001;142:1652-58
47. Grbavec D, Lo R, Liu Y, et al. Transducin-like enhancer of split 2, a mammalian homologue of Drosophila Groucho, acts as a transcriptional repressor, interacts with Hairy/Enhancer of split proteins, and is expressed during neuronal development. Eur J Biochem 1998;258:339-49
48. Cuevas IC, Slocum AL, Jun P, et al. Meningioma transcript profiles reveal deregulated Notch signaling pathway. Cancer Res 2005;65:5070-75
49. Postuma RB, Martins RN, Cappai R, et al. Effects of the amyloid protein precursor of Alzheimer's disease and other ligands of the LDL receptor-related protein on neurite outgrowth from sympathetic neurons in culture. FEBS Lett 1998;428:13-16
50. Paradis E, Julien P, Ven Murthy MR. Requirement for enzymatically active lipoprotein lipase in neuronal differentiation: A site-directed mutagenesis study. Brain Res Dev Brain Res 2004;149:29-37
51. Paradis E, Clavel S, Julien P, et al. Lipoprotein lipase and endothelial lipase expression in mouse brain: Regional distribution and selective induction following kainic acid-induced lesion and focal cerebral ischemia. Neurobiol Dis 2004;15:312-25
52. Navarro A, del Valle E, Tolivia J. Differential expression of apolipoprotein D in human astroglial and oligodendroglial cells. J Histochem Cytochem 2004;52:1031-36
53. del Valle E, Navarro A, Astudillo A, et al. Apolipoprotein D expression in human brain reactive astrocytes. J Histochem Cytochem 2003;51:1285-90
54. Hunter SB, Varma V, Shehata B, et al. Apolipoprotein D expression in primary brain 54.tumors: Analysis by quantitative RT-PCR in formalin-fixed, paraffin-embedded tissue. J Histochem Cytochem 2005;53:963-69
55. Arteaga CL. Epidermal growth factor receptor dependence in human tumors: More than just expression? Oncologist 2002;7:31-39
56. Jones G, Machado J Jr, Merlo A. Loss of focal adhesion kinase (FAK) inhibits epidermal growth factor receptor-dependent migration and induces aggregation of nh(2)-terminal FAK in the nuclei of apoptotic glioblastoma cells. Cancer Res 2001;61:4978-81
57. Brockmann MA, Ulbricht U, Gruner K, et al. Glioblastoma and cerebral microvascular endothelial cell migration in response to tumor-associated growth factors. Neurosurgery 2003;52:1391-99
58. Berens ME, Rief MD, Shapiro JR, et al. Proliferation and motility responses of primary and recurrent gliomas related to changes in epidermal growth factor receptor expression. J Neurooncol 1996;27:11-22
59. Ohgaki H, Dessen P, Jourde B, et al. Genetic pathways to glioblastoma: A population-based study. Cancer Res 2004;64:6892-99
60. Varela M, Ranuncolo SM, Morand A. EGF-R and PDGF-R, but not bcl-2, overexpression predict overall survival in patients with low-grade astrocytomas. J Surg Oncol 2004;86:34-40
61. Lopez-Gines C, Cerda-Nicolas M, Gil-Benso R, et al. Association of chromosome 7, chromosome 10 and EGFR gene amplification in glioblastoma multiforme. Clin Neuropathol 2005;24:209-18
62. Rich JN, Hans C, Jones B, et al. Gene expression profiling and genetic markers in glioblastoma survival. Cancer Res 2005;65:4051-58
63. Tada K, Kochi M, Saya H, et al. Preliminary observations on genetic alterations in pilocytic astrocytomas associated with neurofibromatosis 1. Neurooncology 2003;5:228-34
64. Li J, Perry A, James CD, et al. Cancer-related gene expression profiles in NF1-associated pilocytic astrocytomas. Neurology 2001;56:885-90
65. Walker C, Joyce KA, Thompson-Hehir J, et al. Characterisation of molecular alterations in microdissected archival gliomas. Acta Neuropathol (Berl) 2001;101:21-33
66. Giltname JM, Rimm DL. Technology insight: Identification of biomarkers with tissue microarray technology. Nat Clin Pract Oncol 2004;1:104-11
67. Camby I, Nagy N, Lopes MB, et al. Supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas are characterized by a differential expression of S100 proteins. Brain Pathol 1999;9:1-19
68. Mathieu A, Saal I, Vuckovic A. Nuclear galectin-3 expression is an independent predictive factor of recurrence for adenocarcinoma and squamous cell carcinoma of the lung. Mod Pathol 2005;18:1264-71
69. Wang H, Wang H, Zhang W. Tissue microarrays: Applications in neuropathology research, diagnosis, and education. Brain Pathol 2002;12:95-107